Clinical Trial Update: Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding bevacizumab to adjuvant chemotherapy after surgery benefits patients with high-risk stage II/III colon cancer; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-06